Jump to content

James Linder: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
m adds pic
misc fixes and updates
Line 13: Line 13:
| footnotes =
| footnotes =
}}
}}
'''Dr. James “Jim” Linder, MD''', (born 1954) a noted author, academic and business leader, is an American authority on university research commercialization. <ref>[http://www.aahcdc.org/files/agenda_vp_07.pdf Association of Academic Health Centers, technology transfer conference, June 14, 2007]</ref> He serves as president of the University Technology Development Corp and Chief Strategist for the University of Nebraska System. He is also a professor of pathology and microbiology at the [[University of Nebraska Medical Center]].
'''Dr. James “Jim” Linder, MD''' (born 1954) is a noted author, academic and business leader, and is an American authority on university research commercialization.<ref>[http://www.aahcdc.org/files/agenda_vp_07.pdf Association of Academic Health Centers, technology transfer conference, June 14, 2007]</ref> He serves as president of the University Technology Development Corporation and chief strategist for the [[University of Nebraska system]].<ref>[http://nebraska.edu/technology-developers.html University of Nebraska website]</ref> He is also a professor of pathology and microbiology at the [[University of Nebraska Medical Center]].


==Early life==
==Early life==
A native to Omaha, Linder earned his [[B.S.|B.S. degree]] in [[biochemistry]] and [[microbiology]] from [[Iowa State University]] in 1976, and his [[Doctor of Medicine|M.D. degree]], with distinction, from the University of Nebraska Medical Center in 1980. He completed his residency training in pathology at [[Duke University Medical Center]] and UNMC.
A native to Omaha, Linder earned his [[B.S.|B.S. degree]] in [[biochemistry]] and [[microbiology]] from [[Iowa State University]] in 1976, and his [[Doctor of Medicine|M.D. degree]], with distinction, from the University of Nebraska Medical Center in 1980. He completed his residency training in pathology at [[Duke University Medical Center]] and UNMC.


==Current work==
==Academic activities==
⚫
Linder served as interim president of the [[University of Nebraska system]] from May 2014 until April 2015.<ref>[http://journalstar.com/news/state-and-regional/nebraska/regents-approve-linder-as-interim-nu-president/article_638bf183-dd94-5dac-bfee-505c853ca974.html Lincoln Journal Star, March 21, 2014]</ref> He has served on the UNMC faculty since 1983 when he joined the Pathology and Microbiology department. In 1986 he was named associate professor and in 1989 was named professor. He has held numerous administrative positions at UNMC, including vice chairman of Pathology and Microbiology, director of Surgical Pathology, director of Cytopathology, associate dean for Academic Affairs and interim dean of Medicine. He was associate vice chancellor for Research from 2005-2009, and was responsible for developing clinical research and intellectual property programs at UNMC.<ref>[http://app1.unmc.edu/PublicAffairs/newsarchive/view_art.cfm?article_id=1179 UNeMed news release, September 6, 2005]</ref> He also served as visiting professor at the [[Peter Kiewit Institute]]. In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.<ref>[http://www.unmc.edu/newunemed/index2.php?option=com_content&do_pdf=1&id=46 UNMC news, January 9, 2007]</ref>
⚫
Linder and his wife, [[Karen Linder]], are founders and managing directors of Linseed Capital, LLC, which invests in early stage companies.<ref>[http://linseedcapital.wordpress.com/ Linseed Capital website]</ref>


He serves on editorial boards of several medical journals, and is a former president of the [[American Society for Clinical Pathology]].<ref name="ascp.org">[http://www.ascp.org/AboutUs/newsroom/pdf/July_05_WEB.pdf ''Pathology Today'', July 2005, page 8]</ref> From 1995 to 2007 he was affiliated with [[Cytyc|Cytyc Corporation]], a [[Massachusetts]]-based medical company dedicated to women's health. In 2009 he became founding chief medical officer for [[Constitution Medical Investors]]. Their company was acquired by the [[Roche Diagnostics]] <ref>[http://www.roche.com/media/media_releases/med-cor-2013-07-02.htm Roche Press Release]</ref> in 2013 where he continues as a Chief Medical Officer, developing a hematology analyzer. <ref>[http://bloodhoundcbc.com/ Roche Diagnostics Hematology website]</ref>
He is a former president of the [[American Society for Clinical Pathology]].<ref name="ascp.org">[http://www.ascp.org/AboutUs/newsroom/pdf/July_05_WEB.pdf ''Pathology Today'', July 2005, page 8]</ref>
He is a frequent guest lecturer, and has written five textbooks and more than 130 professional articles.<ref>[http://www.experts.scival.com/nebraska/expertPubs.asp?n=James+Linder&u_id=1765 UNMC website, list of Dr. J. Linder publications]</ref> He serves on several editorial boards, including the ''American Journal of Clinical Pathology''<ref>[http://www.ajcp.com/editorialboard.aspx ''American Journal of Clinical Pathology'', editorial board]</ref> and ''Modern Pathology''.<ref>[http://www.nature.com/modpathol/about.html ''Modern Pathology'', editorial board]</ref> He is a member and has served in leadership positions with many medical organizations, and active in the development of the Interactive Center of the U.S.-Canadian division of the [[International Academy of Pathology]].<ref>[http://www.uscap.org/interactive USCAP Linder Learning Center]</ref>


⚫
He holds numerous patents, and his academic interests include the application of technology in medical diagnostics, including [[immunochemistry]], molecular diagnostics, computer-aided instruction, digital imaging in pathology, and the use of automated techniques in [[cytopathology]] and [[hematology]].
He is a frequent guest lecturer, and has written five textbooks and more than 130 professional articles.<ref>[http://www.experts.scival.com/nebraska/expertPubs.asp?n=James+Linder&u_id=1765 UNMC website, list of Dr. J. Linder publications]</ref>


==Business activities==
He serves on several editorial boards, including the ''American Journal of Clinical Pathology''<ref>[http://www.ajcp.com/editorialboard.aspx ''American Journal of Clinical Pathology'', editorial board]</ref> and ''Modern Pathology''.<ref>[http://www.nature.com/modpathol/about.html ''Modern Pathology'', editorial board]</ref>
⚫
From 1995 to 2007 he served as medical director of [[Cytyc|Cytyc Corporation]], a company based in [Marlborough, Massachusetts|Marlborough]], [[Massachusetts|Mass.]] dedicated to women's health.<ref>[http://ir.cytyc.com/ReleaseDetail.cfm?ReleaseID=175153 Cytyc Corp., news release, September 29, 2005]</ref> A main area of interest was improving [[Pap smear|Pap testing]].


From 2009-13, he was founding chief medical officer for Constitution Medical Investors. The company was later acquired by the [[Roche Diagnostics]]<ref>[http://www.roche.com/media/media_releases/med-cor-2013-07-02.htm Roche Press Release]</ref> in 2013, and Linder stayed on until 2015 and developed a hematology analyzer.<ref>[http://bloodhoundcbc.com/ Roche Diagnostics Hematology website]</ref>where he served as a Chief Medical Officer,
He is a member and has served in leadership positions with many medical organizations, and a member of the Foundation Board of the U.S.-Canadian division of the [[International Academy of Pathology]].<ref>[http://www.uscap.org/foundation-board USCAP Foundation]</ref>


⚫
Linder and his wife, [[Karen Linder]], are founders and managing directors of Linseed Capital, LLC, which invests in early-stage companies.<ref>[http://linseedcapital.wordpress.com/ Linseed Capital website]</ref>
⚫
He holds several patents, and his academic interests include the application of technology in medical diagnostics, including [[immunochemistry]], molecular diagnostics, computer-aided instruction, digital imaging in pathology, and the use of automated techniques in [[cytopathology]] and [[hematology]].


He co-founded Tethon3D, a privately held company based in [[Omaha, Nebraska]] that develops materials for binder-jet ceramic [[3D printing]] and a ceramic resin composite for use in [[stereolithography]] 3D printing.<ref>[http://tethon3d.wordpress.com/ Tethon3D website]</ref>
==Other career highlights==
⚫
Linder served as interim president of the [[University of Nebraska system]] from May, 2014 until April 2015.<ref>[http://journalstar.com/news/state-and-regional/nebraska/regents-approve-linder-as-interim-nu-president/article_638bf183-dd94-5dac-bfee-505c853ca974.html Lincoln Journal Star, March 21, 2014]</ref> He has served on the UNMC faculty since 1983 when he joined the Pathology and Microbiology Department. In 1986, he was named associate professor, and in 1989 was named professor. He has held numerous administrative positions at UNMC, including Vice Chairman of Pathology and Microbiology, Director of Surgical Pathology, Director of Cytopathology, Associate Dean for Academic Affairs and Interim Dean of Medicine. He was Associate Vice Chancellor for Research from 2005-2009, and was responsible for developing clinical research and intellectual property programs at UNMC.<ref>[http://app1.unmc.edu/PublicAffairs/newsarchive/view_art.cfm?article_id=1179 UNeMed news release, September 6, 2005]</ref> He also served as visiting professor at the [[Peter Kiewit Institute]].


He chairs the board of Nobl Health, a company which provides nursing-management software,<ref>[http://noblhealth.com/ Nobl Health website]</ref> and also chairs the scientific advisory board of Streck Corporation, a manufacturer of clinical laboratory products.<ref>[http://www.streck.com/ Streck Corporation website]</ref>. He is board member and secretary of [[Nebraska Medicine]], the health system for the University of Nebraska Medical Center.
In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.<ref>[http://www.unmc.edu/newunemed/index2.php?option=com_content&do_pdf=1&id=46 UNMC news, January 9, 2007]</ref>
⚫
With Cytyc Corporation, a women's health company located in [[Marlborough, Massachusetts|Marlborough]], [[Massachusetts|Mass.]], he served as medical director or Chief Medical Officer from 1995-07.<ref>[http://ir.cytyc.com/ReleaseDetail.cfm?ReleaseID=175153 Cytyc Corp., news release, September 29, 2005]</ref> A main area of interest was improving [[Pap smear|Pap testing]].

From 1998-99, he was president of the American Society of Clinical Pathologists.


==Awards, honors, community service==
==Awards, honors, community service==
Linder has been accorded many professional honors and awards. In 2015, recognizing his accomplishments in laboratory medicine and technology transfer, he was inducted as a Fellow of the National Academy of Inventors<ref>[http://www.prnewswire.com/news-releases/national-academy-of-inventors-names-170-new-fellows-300010066.html]</ref> In 2014 he and Karen Linder received the Entrepreneurial Leadership Award. <ref>[http://www.nebraskaentrepreneurship.com/news/pipeline-announces-innovator-of-the-year-and-new-fellows/ Nebraskaentrepreneurship news release]</ref> In 2013 Linseed Capital was recognized as Investor of the Year in the Silicon Prairie <ref>[http://www.siliconprairienews.com/2013/08/and-the-12-winners-of-the-2013-silicon-prairie-awards-are Siliconprairie News]</ref> In 2005, he was presented with the American Society of Clinical Pathologists "Israel Davidsohn Award for Distinguished Service".
Linder has been accorded several professional honors and awards. In 2015, recognizing accomplishments in laboratory medicine and technology transfer, he was inducted as a fellow of the National Academy of Inventors.<ref>[http://www.prnewswire.com/news-releases/national-academy-of-inventors-names-170-new-fellows-300010066.html National Academy 2015 Inductees]</ref> In 2014 he and Karen Linder received the Entrepreneurial Leadership Award.<ref>[http://www.nebraskaentrepreneurship.com/news/pipeline-announces-innovator-of-the-year-and-new-fellows/ Nebraska Entrepreneurship news release]</ref> In 2013 Linseed Capital was recognized as Investor of the Year by the Silicon Prairie News.<ref>[http://www.siliconprairienews.com/2013/08/and-the-12-winners-of-the-2013-silicon-prairie-awards-are Silicon Prairie News]</ref> In 2005, he was presented with the [[American Society of Clinical Pathologists]]' "Israel Davidsohn Award for Distinguished Service."


From 1999-2001, he served on the board of directors of the Omaha Children’s Museum, and has served as chairman of the board of [[KANEKO]], an organization devoted to fostering creativity in design and entrepreneurship.<ref>[http://www.thekaneko.org/ KANEKO Open Space for your mind, Omaha]</ref> He also is a regional board member of the Pipeline Entrepreneurship Program.<ref>[http://www.omaha.com/article/20130120/MONEY/701209905 Omaha.com, January 20, 2013]</ref> He also serves on the boards of the Nebraska Advanced Manufacturing Council, and the University of Nebraska Foundation.
From 1999-2001, he served on the board of directors of the Omaha Children’s Museum. He has served as chairman of the board of KANEKO, an organization devoted to fostering creativity, and serves as chair of the Kaneko Creative Council.<ref>[http://www.thekaneko.org/ KANEKO Open Space for your mind, Omaha]</ref> He also is a regional board member of the Pipeline Entrepreneurship Program.<ref>[http://www.omaha.com/article/20130120/MONEY/701209905 Omaha World Herald, January 20, 2013]</ref>


==Personal and family==
==Personal and family==
Linder is married to [[Karen Linder]] SCT(ASCP), author of ''The Women of Berkshire Hathaway''.<ref>[http://womenofberkshire.wordpress.com/author/curlyjack/ Wordpress website]</ref>
Linder is married to [[Karen Linder]] SCT(ASCP), president of Tethon 3D<ref>[http://tethon3d.wordpress.com/ Tethon3D website]</ref> and author of ''The Women of Berkshire Hathaway''.<ref>[http://womenofberkshire.wordpress.com/author/curlyjack/ Women of Berkshire Hathaway]</ref>


==References==
==References==
{{reflist}}
{{reflist|30em}}


{{s-start}}
{{s-start}}

Revision as of 02:09, 25 July 2016

Dr. James Linder
File:James Linder from Nebraska.jpg
Born (1954-10-21) October 21, 1954 (age 69)
Omaha, NE
Alma materB.S., Iowa State University, 1976
M.D., cum laude, UNMC, 1980
Residency, Duke, UNMC
Occupation(s)Pathologist, Business Executive
SpouseKaren Linder
Children4 sons, 2 daughters

Dr. James “Jim” Linder, MD (born 1954) is a noted author, academic and business leader, and is an American authority on university research commercialization.[1] He serves as president of the University Technology Development Corporation and chief strategist for the University of Nebraska system.[2] He is also a professor of pathology and microbiology at the University of Nebraska Medical Center.

Early life

A native to Omaha, Linder earned his B.S. degree in biochemistry and microbiology from Iowa State University in 1976, and his M.D. degree, with distinction, from the University of Nebraska Medical Center in 1980. He completed his residency training in pathology at Duke University Medical Center and UNMC.

Academic activities

Linder served as interim president of the University of Nebraska system from May 2014 until April 2015.[3] He has served on the UNMC faculty since 1983 when he joined the Pathology and Microbiology department. In 1986 he was named associate professor and in 1989 was named professor. He has held numerous administrative positions at UNMC, including vice chairman of Pathology and Microbiology, director of Surgical Pathology, director of Cytopathology, associate dean for Academic Affairs and interim dean of Medicine. He was associate vice chancellor for Research from 2005-2009, and was responsible for developing clinical research and intellectual property programs at UNMC.[4] He also served as visiting professor at the Peter Kiewit Institute. In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.[5]

He is a former president of the American Society for Clinical Pathology.[6] He is a frequent guest lecturer, and has written five textbooks and more than 130 professional articles.[7] He serves on several editorial boards, including the American Journal of Clinical Pathology[8] and Modern Pathology.[9] He is a member and has served in leadership positions with many medical organizations, and active in the development of the Interactive Center of the U.S.-Canadian division of the International Academy of Pathology.[10]

He holds numerous patents, and his academic interests include the application of technology in medical diagnostics, including immunochemistry, molecular diagnostics, computer-aided instruction, digital imaging in pathology, and the use of automated techniques in cytopathology and hematology.

Business activities

From 1995 to 2007 he served as medical director of Cytyc Corporation, a company based in [Marlborough, Massachusetts|Marlborough]], Mass. dedicated to women's health.[11] A main area of interest was improving Pap testing.

From 2009-13, he was founding chief medical officer for Constitution Medical Investors. The company was later acquired by the Roche Diagnostics[12] in 2013, and Linder stayed on until 2015 and developed a hematology analyzer.[13]where he served as a Chief Medical Officer,

Linder and his wife, Karen Linder, are founders and managing directors of Linseed Capital, LLC, which invests in early-stage companies.[14]

He co-founded Tethon3D, a privately held company based in Omaha, Nebraska that develops materials for binder-jet ceramic 3D printing and a ceramic resin composite for use in stereolithography 3D printing.[15]

He chairs the board of Nobl Health, a company which provides nursing-management software,[16] and also chairs the scientific advisory board of Streck Corporation, a manufacturer of clinical laboratory products.[17]. He is board member and secretary of Nebraska Medicine, the health system for the University of Nebraska Medical Center.

Awards, honors, community service

Linder has been accorded several professional honors and awards. In 2015, recognizing accomplishments in laboratory medicine and technology transfer, he was inducted as a fellow of the National Academy of Inventors.[18] In 2014 he and Karen Linder received the Entrepreneurial Leadership Award.[19] In 2013 Linseed Capital was recognized as Investor of the Year by the Silicon Prairie News.[20] In 2005, he was presented with the American Society of Clinical Pathologists' "Israel Davidsohn Award for Distinguished Service."

From 1999-2001, he served on the board of directors of the Omaha Children’s Museum. He has served as chairman of the board of KANEKO, an organization devoted to fostering creativity, and serves as chair of the Kaneko Creative Council.[21] He also is a regional board member of the Pipeline Entrepreneurship Program.[22]

Personal and family

Linder is married to Karen Linder SCT(ASCP), president of Tethon 3D[23] and author of The Women of Berkshire Hathaway.[24]

References

  1. ^ Association of Academic Health Centers, technology transfer conference, June 14, 2007
  2. ^ University of Nebraska website
  3. ^ Lincoln Journal Star, March 21, 2014
  4. ^ UNeMed news release, September 6, 2005
  5. ^ UNMC news, January 9, 2007
  6. ^ Pathology Today, July 2005, page 8
  7. ^ UNMC website, list of Dr. J. Linder publications
  8. ^ American Journal of Clinical Pathology, editorial board
  9. ^ Modern Pathology, editorial board
  10. ^ USCAP Linder Learning Center
  11. ^ Cytyc Corp., news release, September 29, 2005
  12. ^ Roche Press Release
  13. ^ Roche Diagnostics Hematology website
  14. ^ Linseed Capital website
  15. ^ Tethon3D website
  16. ^ Nobl Health website
  17. ^ Streck Corporation website
  18. ^ National Academy 2015 Inductees
  19. ^ Nebraska Entrepreneurship news release
  20. ^ Silicon Prairie News
  21. ^ KANEKO Open Space for your mind, Omaha
  22. ^ Omaha World Herald, January 20, 2013
  23. ^ Tethon3D website
  24. ^ Women of Berkshire Hathaway
Preceded by President of American Society for Clinical Pathology
1998–1999 		Succeeded by
Retrieved from "https://en.wikipedia.org/w/index.php?title=James_Linder&oldid=731392245"